1. Home
  2. CZWI vs TTRX Comparison

CZWI vs TTRX Comparison

Compare CZWI & TTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Community Bancorp Inc.

CZWI

Citizens Community Bancorp Inc.

HOLD

Current Price

$22.90

Market Cap

197.5M

Sector

Finance

ML Signal

HOLD

Logo Turn Therapeutics Inc.

TTRX

Turn Therapeutics Inc.

HOLD

Current Price

$5.99

Market Cap

174.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CZWI
TTRX
Founded
1938
2015
Country
United States
United States
Employees
N/A
2
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.5M
174.9M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
CZWI
TTRX
Price
$22.90
$5.99
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
99.5K
58.2K
Earning Date
04-27-2026
05-31-2026
Dividend Yield
2.02%
N/A
EPS Growth
8.96
N/A
EPS
0.39
N/A
Revenue
N/A
N/A
Revenue This Year
$13.02
N/A
Revenue Next Year
$9.42
N/A
P/E Ratio
$56.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.63
$2.57
52 Week High
$22.62
$6.75

Technical Indicators

Market Signals
Indicator
CZWI
TTRX
Relative Strength Index (RSI) 70.56 56.63
Support Level $20.10 $4.70
Resistance Level N/A $6.68
Average True Range (ATR) 0.82 0.56
MACD 0.20 -0.06
Stochastic Oscillator 96.69 53.36

Price Performance

Historical Comparison
CZWI
TTRX

About CZWI Citizens Community Bancorp Inc.

Citizens Community Bancorp Inc is a bank holding company that offers traditional community banking services to businesses, Agricultural operators, and consumers, including one-to-four-family residential mortgages. it also offers a variety of loan products including commercial real estate loans, commercial and industrial (C&I) loans, agricultural real estate loans, agricultural operating loans, residential mortgages, home equity lines-of-credit, and consumer loans and offers deposit products through its branches, including demand deposits, various savings and money-market accounts and certificates of deposit. The company's sources of funds are deposits; amortization, prepayments, and maturities of outstanding loans; other short - term investments; and funds provided from operations.

About TTRX Turn Therapeutics Inc.

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Share on Social Networks: